Jan 15 (Reuters) - Moberg Pharma Ab (Publ):
* MOBERG PHARMA RECEIVES FAVORABLE OUTCOME FROM NAD - MAIN COMPETITOR TO DISCONTINUE CURRENT MARKETING
* EXPECTS OUTCOME TO FURTHER STRENGTHEN KERASAL NAILSÂ® POSITION AND GROWTH PROSPECTS IN U.S. MARKET Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 